• Careers
Contact

Mansfield is a leading healthcare and life sciences strategy consulting firm as ranked by the Financial Times and Vault

We advise on corporate strategy, value creation and commercial due diligence by combining research, modelling and analysis with clinical, scientific and operational knowledge

Selected Clients and Assets we have worked on

Our Latest Insights

Expert analysis across healthcare, life sciences, pharma, social care and digital

Pet Food 2036: Growth and Disruption in Cat and Dog Food
Pet Food 2036: Growth and Disruption in Cat and Dog Food
Animal Health
Radiopharmaceuticals – where hot molecules meet cold capital
Radiopharmaceuticals – where hot molecules meet cold capital
Therapeutic Products and Innovation
GLP-1 2.0: Where the next wave of value will be created
GLP-1 2.0: Where the next wave of value will be created
Therapeutic Products and Innovation
Investing in the Mind: Why Tech-Enabled Mental Health is a Private Equity Priority
Investing in the Mind: Why Tech-Enabled Mental Health is a Private Equity Priority
Health & Care
Spanish PE Deals: Max Taylor and Pauline Fontaine take a closer look at the most active funds in the market, and what they invest in
Spanish PE Deals: Max Taylor and Pauline Fontaine take a closer look at the most active funds in the market, and what they invest in
Investment
Will primary care always be secondary for investors?
Will primary care always be secondary for investors?
Health & Care
Three key lessons for digital health investors from the demise of Babylon Health
Three key lessons for digital health investors from the demise of Babylon Health
Health & Care
A Quick Update on NHS Waiting Lists
A Quick Update on NHS Waiting Lists
Health & Care
The Evolving Roles of CDMOs
The Evolving Roles of CDMOs
Investment
Taking a closer look at French PE deals, the most active funds in the market, and what they invest in
Taking a closer look at French PE deals, the most active funds in the market, and what they invest in
Animal Health
View all

News & Insights

Healthcare news, data and analysis

Via Investors in Healthcare

Demetra,  an Italy-based independent medical company providing anti-infective cements, spacers and biomaterials for orthopaedic applications, has acquired Maxxspine Innovative, a German-based company specialising in advanced spinal surgery solutions. The transaction strengthens […]
Germany: Demetra strengthens its position in spine surgery with acquisition of Maxxspine Innovative
30 April 2026
Life Sciences ,
M&A ,
Medtech – Medical Devices and Implants ,
News ,
Demetra
Chiesi Group, an Italy-based, family-controlled, international research-focused biopharmaceutical group and certified B Corp, is acquiring Nasdaq-listed KalVista Pharmaceuticals, a global pharmaceutical company focused on addressing the critical unmet needs of […]
Italy: Chiesi Group expanding global Rare Disease portfolio with US$1.9bn acquisition of KalVista
30 April 2026
M&A ,
Manufacturing – Specialty Pharma ,
News ,
Pharma ,
Ben Palleiko
Archimed Diagnostics – the diagnostics team of France‑based global healthcare private equity specialist Archimed – has acquired Stago, a world leader in haemostasis analysis. Stago, headquartered in France, develops and […]
France: Stago accelerating growth with Archimed and La Caisse
29 April 2026
Buy Out ,
IVD – Tools ,
Life Sciences ,
M&A ,
Medtech – Diagnostics
NIB, the international financial institution of Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, and Sweden, has signed an ISK4.4bn (US$36m) 10-year indexed loan with the listed Icelandic real estate company Reitir hf. The loan will […]
Iceland: NIB finances nursing home and healthcare facilities in Reykjavik 
29 April 2026
Care Homes ,
Debt ,
Healthcare ,
Hospitals and Clinics ,
News
vVardis Holding, a Switzerland-based dental medtech company pioneering non-invasive cavity treatment, has achieved unicorn status following a strategic minority investment from US-based Apollo-managed funds. The investment establishes vVardis as one […]
Switzerland: vVardis reaches unicorn status following investment from Apollo
29 April 2026
Dental ,
Healthcare ,
News ,
Venture ,
Andrea Vanni
Echosens, a France-based specialist diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases, has appointed Romain Baujard as group […]
France: Echosens appoints Romain Baujard as group CEO
28 April 2026
Diagnostics ,
Healthcare ,
News ,
People ,
Astorg
Salt Capital, a private equity investment firm focused on growth capital investments in the SADC region, and Proparco, the French Development finance institution, have acquired The Namibian Oncology Centre (NOC), […]
Namibia: Salt Capital and Proparco acquire The Namibian Oncology Centre
28 April 2026
Buy Out ,
Healthcare ,
Hospitals and Clinics ,
M&A ,
M&A Deals
UK-based business challenger bank, Allica Bank, is announced it is expanding its lending and product flexibility in support of UK healthcare operators. The changes enable the bank to better support […]
UK: Allica Bank expands lending and products in support of healthcare businesses
28 April 2026
Debt ,
Healthcare ,
News ,
Allica Bank ,
Anthony Newman
Astorg, a pan European private equity firm, has signed a definitive agreement to acquire New York-listed Thermo Fisher Scientific’s microbiology business for approximately US$1.075bn, consisting of cash and a US$50m […]
Luxembourg: Astorg to acquire Thermo Fisher Scientific’s microbiology business for US$1.075bn
27 April 2026
Buy Out ,
Life Sciences ,
M&A ,
Medtech – Diagnostics ,
News
France-headquartered Servier, an independent international pharmaceutical group governed by a foundation, has acquired Nasdaq-listed Day One Biopharmaceuticals, a biopharmaceutical company developing and commercialising targeted therapies for people of all ages […]
France: Servier acquires Day One Bio for US$2.5bn
27 April 2026
M&A ,
Manufacturing – Specialty Pharma ,
News ,
Pharma ,
Day One Bio
Netherlands-based independent PE investment group, Waterland, has announced the closing of its 10th institutional flagship fund Waterland Private Equity Fund X (WPEF X) at €4bn (US$4.7bn), alongside Waterland Partnership Fund II […]
Netherlands: Waterland raises €4.6bn in less than four months
27 April 2026
Buy Out ,
Healthcare ,
News ,
Cedric Van Cauwenberghe ,
Evercore
Panthera Biopartners (Panthera), the LDC-backed UK based clinical trial Site Management Organisation (SMO), has announced the acquisition of Óbudai Egészségügyi Centrum Kft (OEC), a Hungary-based independent clinical research site network. […]
Hungary: LDC-backed Panthera Biopartners takes first major step in European expansion strategy
27 April 2026
Buy Out ,
M&A ,
News ,
Pharma ,
Services – CRO/CMO/CDMO
Partners Group, one of the largest firms in the global private markets industry, has closed its eighth private equity secondaries programme with over US$9bn in total client commitments. The programme […]
Switzerland: Partners Group closes latest private equity secondaries programme with over US$9bn of total commitments
24 April 2026
Buy Out ,
News ,
Anthony Shontz ,
Partners Group ,
Switzerland
Northern Horizon, the leading specialised social infrastructure investment manager in the Nordics, closed the first quarter of 2026 with another funding round of approximately €100m (US$117m) for its flagship evergreen […]
Sweden: Northern Horizon announces second fund raise in Q1 2026
24 April 2026
Care Homes ,
News ,
Real Assets ,
Social Care ,
Christoffer Abramson
Alcami Corporation, a US-based CDMO, is acquiring Tjoapack, a Netherlands-based global contract packaging organisation (CPO) serving the pharmaceutical and biotech industries. Ampersand Capital Partners acquired a majority stake in Tjoapack […]
Netherlands: Alcami to acquire contract packaging organisation Tjoapack
24 April 2026
Buy Out ,
M&A ,
News ,
Pharma ,
Services – CRO/CMO/CDMO
Kurma Partners, a European healthcare venture capital firm and a Eurazeo group company, has announced the final closing of Biofund IV at €215m (US$252m), some 35% larger than its previous […]
France: Kurma Partners closes Biofund IV at €215m
23 April 2026
Healthcare ,
Life Sciences ,
News ,
Pharma ,
Venture
InnoDiab Forschung, a specialised clinical research centre, has joined Certainia’s Life Sciences segment, strengthening Certania’s capabilities in diabetes, obesity and related metabolic diseases. “InnoDiab expands our Life Sciences clinical research […]
Germany: Innodiab expands Certania’s Life Sciences capabilities in diabetes and obesity
23 April 2026
Buy Out ,
M&A ,
News ,
Pharma ,
Services – CRO/CMO/CDMO
Bay Tree Private Equity, a UK-based private equity firm investing in lower mid-market businesses, has completed an investment in Medicare Insourcing Services, a provider of clinical insourcing services to the […]
UK: Bay Tree completes investment in Medicare Insourcing Services
23 April 2026
Debt ,
Diagnostics ,
Healthcare ,
M&A ,
News
Against a backdrop of geopolitical tension, valuation resets and shifting capital markets, life sciences dealmaking is not slowing, it is recalibrating. The tone at McDermott Will & Schulte’s Life Sciences […]
From uncertainty to opportunity: life sciences dealmaking resets – Insights from McDermott Will & Schulte’s Life Sciences Symposium
22 April 2026
Analysis ,
Life Sciences ,
News ,
Aymen Mahmoud ,
Emmanuelle Trombe
Praemia REIM, a key European real estate asset management player with an asset portfolio over half of which is in the healthcare/education sector, has appointed Lionel Paquin as Group CEO as part of […]
France: Praemia REIM appoints Lionel Paquin as CEO
22 April 2026
Care Homes ,
Education ,
Healthcare ,
News ,
People
Nasdaq-listed QuidelOrtho Corporation, a global leader of innovative in vitro diagnostics, has completed the acquisition of LEX Diagnostics for approximately US$100m. LEX Diagnostics is a UK-based molecular diagnostics company and a spin-out […]
UK: QuidelOrtho aquires LEX Diagnostics from TTP Group for US$100m
21 April 2026
Diagnostics ,
Healthcare ,
Life Sciences ,
M&A ,
Medtech – Hospital Equipment
Listed Advanced Medical Solutions (AMS) has confirmed it is in discussions with TA Associates, a US private equity firm investment team specialising in five target industries: technology, financial services, healthcare, […]
UK: AMS confirms discussions with TA Associates regarding a possible takeover
20 April 2026
Life Sciences ,
M&A ,
Medtech – Medical Devices and Implants ,
News ,
Public Equity
Germany-based real estate platform Carestone specialises in the development, construction and sale of senior living and care home assets. Headquartered in Hanover, it has become one of the leading developers […]
Financing the future of elderly care in Germany: Carestone CEO Daniel Ahrendt talks market dynamics and growth
20 April 2026
Analysis ,
Care Homes ,
News ,
Real Assets ,
Social Care
Northern Horizon, a specialised social infrastructure asset manager in the Nordics, has completed three forward funding deals acquisitions in Finland for approximately €28m. The new assets – in Jyväskylä, Pori and Kuopio […]
Finland: Northern Horizon expands in Finland through three forward-funding deals
20 April 2026
Care Homes ,
News ,
Real Assets ,
Social Care ,
Finland
Affidea, a Netherlands-based leading pan-European provider of community-based polyclinics, specialised services and advanced diagnostics, has transferred its operations in Hungary to local healthcare provider Medicare Group. Formed in Hungary in 1998, […]
Hungary: Affidea exits Hungary with operations transferring to Medicare Group
20 April 2026
Diagnostics ,
Healthcare ,
M&A ,
News ,
Affidea